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in the most appropriate host, to examine the 
host-pathogen interactions that occur in 
outbred populations. A fundamental point 
in the development of new and improved 
intervention strategies is the understanding 
of host differences in the innate immune 
response, which primes the subsequent 
adaptive immune response. Although the 
innate immune system has been largely 
conserved during evolution, marked 
variations and diversity exist between dif-
ferent mammalian species within Pattern-
Recognition-Receptor (PRR) structure 
(Jungi et al., 2011). These differences are 
based on evolutionary pressure within the 
innate immune system, potentially reflect-
ing the specific threats encountered by each 
species (Zhang et al., 2010). This selective 
pressure appears to be absent in the avail-
able murine sequences (Werling et al., 
2009). The similarity between human and 
farm animal PRR (Jungi et al., 2011) is fur-
ther supported by their similar response to 
ligands (Kapetanovic et al., 2012), in con-
trast to murine PRR (Hajjar et al., 2002; 
Grabiec et al., 2004; Farhat et al., 2010). 
Since recognition by PRR is associated with 
adaptive immunity by providing optimal 
immunostimulation, learning more about 
these key molecules in farm animals might 
inform us about their adjuvant effect in 
vaccines for use in these animals as well 
as humans. Given the size and blood vol-
umes of farm animals, there are also greater 
opportunities to repeatedly access to differ-
ent cell types – an asset which would facili-
tate the assessment of cell specific effects of 
such immunomodulatory agents on autol-
ogous cells (Hein and Griebel, 2003). Farm 
animal models do have their disadvantages 
such as dedicated housing, biosecurity, 
and the confinement of infected animals. 
However, it is  misleading to rely on murine 
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In recent decades the inappropriate use 
of antibiotics in farm animals, either as 
growth enhancers or for treatment of infec-
tious diseases, has resulted both in higher 
concentrations of antibiotic residues in 
meat destined for the human food chain 
and in an increasing prevalence of antibi-
otic-resistant bacteria (Carlet et al., 2012). 
Increased public concerns regarding their 
potential impact on human health may 
result in a reduction or cessation in the use 
of antibiotics in farm animals (Veterinary 
Record, 2011, 2012). Thus, alternative treat-
ments for the control of infectious diseases 
in farm animals need to be identified as a 
research priority. In achieving this goal, the 
physiological relevance of an animal model 
to the intended target population becomes 
a key factor. The majority of models cur-
rently used for pharmaceutical research are 
murine and it is possible that potentially 
valuable therapeutics are discounted on 
the basis of lack of responses generated in 
this system, as shown very recently for sep-
sis (Seok et al., 2013). Several non-rodent 
species, such as cattle, pigs, and chicken, 
are both valuable models for infectious 
diseases in humans (Hein and Griebel, 
2003; Visscher and Goddard, 2011; Waters 
et al., 2011; Costa et al., 2012; Meurens 
et al., 2012) and important clinical targets 
in their own right. Effective vaccines have 
been developed for many acute viral and 
bacterial infections, whereas for others, 
like tuberculosis (TB), there is still a need 
for reliable vaccines. Pathology seen in the 
murine models of TB currently used is very 
different to the pathology seen in humans 
(Gupta and Katoch, 2009), whereas the 
bovine and human diseases share many 
similarities (Waters et al., 2011). For such 
diseases it is crucial that we use natural dis-
ease-models, with the appropriate pathogen 
models to fill the gaps in our knowledge 
of disease-pathogenesis, and choosing a 
research model should be more than just 
a matter of convenience and convention 
(Bolker, 2012).
However, in addition to their potential 
use as models for human diseases, research 
in farm-animals models have a “right-on-
their-own,” taken the predicted increase in 
food supply necessary by 70% to support 
an ever-increasing global population as well 
as the occurrence of new emerging diseases, 
such as Schmallenberg virus into account. 
These challenges can be faced and overcome 
by an increased readiness of farm animal 
research centers to apply their models in 
novel ways, a willingness of the medical 
profession to accept more suitable disease-
models, and a willingness of funding agen-
cies and companies to invest in this type of 
research partnership.
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